Form 4: NeueHealth Director Manuel Kadre Reports Stock Transactions

Director Manuel Kadre reports acquisition and disposal of NeueHealth, Inc. stock and restricted stock units on May 13, 2025.

Summary

• On May 13, 2025, Manuel Kadre, a director of NeueHealth, Inc., reported transactions involving the company's stock.
• Kadre acquired 10,500 shares of common stock at $0.
• He also disposed of 29,820 shares of common stock.
• Additionally, Kadre acquired 10,500 restricted stock units, which convert to common stock.
• Following these transactions, Kadre directly owns 0 derivative securities and indirectly owns 3,686 shares through Kadre Family Partnership, L.P.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company directors and officers.

Stakeholder Impact

• Shareholders can use this information to understand the actions of company insiders and their confidence in the company's prospects.

Key Dates

Keywords

Form 4, NeueHealth, Director, Stock, Manuel Kadre, Restricted Stock Units, Beneficial Ownership, Transactions